Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis

Carlos E Builes-Montaño, Andres F Suarez-Rodriguez, Maria A Alzate-Vinasco · 2026

Read Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis by Carlos E Builes-Montaño, Andres F Suarez-Rodriguez, Maria A Alzate-Vinasco (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13388875.txt.

Description

Builes-Montaño and colleagues model the dose-response curves of the leading incretin weight-loss drugs, semaglutide and tirzepatide, to find which doses are clinically interchangeable in type 2 diabetes, in 2026 pharmacology research. Arm-level data came from the phase III trial programs of both drugs: 48 treatment arms covering 16,524 participants. Statistical models traced weight change across doses, and Bayesian analysis estimated the probability that dose pairs differ by less than a pre-set equivalence margin of 2 percentage points.

Both drugs showed nonlinear dose-response, with each dose step buying less loss than the last at higher doses. Equivalence probabilities were high for two pairings. Semaglutide 2.4 milligrams matched tirzepatide 10 milligrams with 99.4 percent probability, and semaglutide 7.2 milligrams matched tirzepatide 15 milligrams with 94.8 percent probability in the model. Lower semaglutide doses were not equivalent to higher tirzepatide doses. Builes-Montaño offers the map for clinicians switching patients between the drugs without losing ground.

Catalog record

CREATORCarlos E Builes-Montaño, Andres F Suarez-Rodriguez, Maria A Alzate-Vinasco
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13388875

Browse the full library · About the Tower of Babel